Difficulty: Medium
Average Score: 88%
Practice
A 45-year-old patient who is taking a proton pump inhibitor, metronidazole, and clarithromycin. Which of the following is the most likely purpose for administering this drug combination?
Correct answer
C
Rationale
The correct answer is C) Refractory or recurrent, and severe, gastric or duodenal ulcers secondary to H. pylori.
This drug combination of a proton pump inhibitor, metronidazole, and clarithromycin is commonly used to eradicate Helicobacter pylori (H. pylori) infection in patients with persistent, severe, or recurrent gastric or duodenal ulcers. H. pylori is a major cause of peptic ulcers, and eradicating this bacterial infection helps in healing and preventing the recurrence of ulcers.
Option A, Antibiotic-associated pseudomembranous colitis, is treated with different antibiotics like vancomycin or fidaxomicin, not with the combination mentioned.
Option B, Irritable bowel syndrome (IBS), is a chronic functional gastrointestinal disorder that does not typically require treatment with this specific drug combination.
Option D, Traveler's diarrhea, is usually caused by bacterial pathogens like Escherichia coli and is typically treated with antibiotics like azithromycin or fluoroquinolones, rather than the combination provided.
Educationally, understanding the rationale behind using specific drug combinations for certain conditions is crucial for healthcare professionals to make informed decisions in clinical practice and provide optimal patient care based on evidence-based guidelines and treatment protocols.
This drug combination of a proton pump inhibitor, metronidazole, and clarithromycin is commonly used to eradicate Helicobacter pylori (H. pylori) infection in patients with persistent, severe, or recurrent gastric or duodenal ulcers. H. pylori is a major cause of peptic ulcers, and eradicating this bacterial infection helps in healing and preventing the recurrence of ulcers.
Option A, Antibiotic-associated pseudomembranous colitis, is treated with different antibiotics like vancomycin or fidaxomicin, not with the combination mentioned.
Option B, Irritable bowel syndrome (IBS), is a chronic functional gastrointestinal disorder that does not typically require treatment with this specific drug combination.
Option D, Traveler's diarrhea, is usually caused by bacterial pathogens like Escherichia coli and is typically treated with antibiotics like azithromycin or fluoroquinolones, rather than the combination provided.
Educationally, understanding the rationale behind using specific drug combinations for certain conditions is crucial for healthcare professionals to make informed decisions in clinical practice and provide optimal patient care based on evidence-based guidelines and treatment protocols.